Logerfo Michael
Insider CIK 1518010 · SGNT President, CLO and Secretary
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SGNT Sagent Pharmaceuticals, In | F Tax w/h | 2016-02-25 | 2016-02-26 | 402 | $14.58 | $5.9K | 53,292 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | F Tax w/h | 2016-02-22 | 2016-02-23 | 486 | $14.61 | $7.1K | 53,694 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | F Tax w/h | 2016-02-21 | 2016-02-23 | 744 | $14.61 | $10.9K | 54,180 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | F Tax w/h | 2016-02-18 | 2016-02-22 | 634 | — | $0 | 54,924 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | F Tax w/h | 2015-12-31 | 2016-01-05 | 924 | $15.85 | $14.6K | 55,558 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | M Exercise deriv | 2015-05-11 | 2015-05-13 | 2,759 | — | $0 | 10,000 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | M Exercise | 2015-05-11 | 2015-05-13 | 2,759 | $4.31 | $11.9K | 56,482 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | A Award | 2015-03-30 | 2015-04-01 | 5,480 | — | $0 | 53,723 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | A Award deriv | 2015-02-25 | 2015-02-27 | 8,208 | — | $0 | 8,208 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | A Award | 2015-02-25 | 2015-02-27 | 4,420 | — | $0 | 48,243 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | F Tax w/h | 2015-02-22 | 2015-02-24 | 429 | $28.50 | $12.2K | 43,823 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | F Tax w/h | 2015-02-21 | 2015-02-24 | 637 | $28.50 | $18.2K | 44,252 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | F Tax w/h | 2015-02-18 | 2015-02-20 | 581 | $27.22 | $15.8K | 44,889 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | G Gift | 2014-12-30 | 2014-12-30 | 300 | — | $0 | 45,470 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | M Exercise deriv | 2014-07-25 | 2014-07-29 | 12,759 | — | $0 | 0 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | M Exercise | 2014-07-25 | 2014-07-29 | 12,759 | $4.31 | $55.0K | 45,770 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | S Sale | 2014-02-27 | 2014-02-28 | 2,021 | $21.43 | $43.3K | 33,011 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | F Tax w/h | 2014-02-22 | 2014-02-24 | 441 | $21.75 | $9.6K | 35,032 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | F Tax w/h | 2014-02-21 | 2014-02-24 | 590 | $21.84 | $12.9K | 35,473 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | M Exercise deriv | 2014-02-20 | 2014-02-24 | 20,000 | — | $0 | 0 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | S Sale | 2014-02-20 | 2014-02-24 | 3,894 | $21.78 | $84.8K | 36,063 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | S Sale | 2014-02-20 | 2014-02-24 | 4,638 | $22.05 | $102.3K | 19,957 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | M Exercise | 2014-02-20 | 2014-02-24 | 20,000 | $4.23 | $84.6K | 39,957 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | A Award deriv | 2014-02-18 | 2014-02-19 | 10,638 | — | $0 | 10,638 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | A Award | 2014-02-18 | 2014-02-19 | 5,952 | — | $0 | 24,595 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | G Gift | 2013-12-24 | 2013-12-26 | 1,400 | — | $0 | 18,643 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | F Tax w/h | 2013-02-22 | 2013-12-26 | 506 | $16.85 | $8.5K | 20,043 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | A Award deriv | 2013-02-21 | 2013-02-25 | 12,067 | — | $0 | 12,067 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | A Award | 2013-02-21 | 2013-02-25 | 6,991 | — | $0 | 20,549 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | G Gift | 2012-12-28 | 2012-12-31 | 1,300 | — | $0 | 13,558 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | G Gift | 2012-12-12 | 2012-12-13 | 3,000 | — | $0 | 14,858 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | M Exercise deriv | 2012-11-20 | 2012-11-21 | 4,243 | — | $0 | 19,999 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | M Exercise | 2012-11-20 | 2012-11-21 | 4,243 | $4.23 | $17.9K | 17,858 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | S Sale | 2012-11-19 | 2012-11-20 | 6,867 | $14.64 | $100.5K | 13,615 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | S Sale | 2012-11-16 | 2012-11-20 | 2,271 | $14.68 | $33.3K | 20,482 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | M Exercise deriv | 2012-11-15 | 2012-11-16 | 17,338 | — | $0 | 0 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | M Exercise | 2012-11-15 | 2012-11-16 | 17,338 | $4.23 | $73.3K | 31,753 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | S Sale | 2012-11-15 | 2012-11-16 | 9,000 | $14.38 | $129.4K | 22,753 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | M Exercise deriv | 2012-11-14 | 2012-11-16 | 1,800 | — | $0 | 17,338 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | S Sale | 2012-11-14 | 2012-11-16 | 1,000 | $14.56 | $14.6K | 14,415 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | M Exercise | 2012-11-14 | 2012-11-16 | 1,800 | $4.23 | $7.6K | 15,415 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | S Sale | 2012-05-25 | 2012-05-29 | 7,000 | $15.86 | $111.0K | 13,615 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | P Buy | 2012-05-17 | 2012-05-18 | 2,000 | $15.69 | $31.4K | 20,615 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | A Award deriv | 2012-02-22 | 2012-02-24 | 9,330 | — | $0 | 9,330 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | A Award | 2012-02-22 | 2012-02-24 | 5,220 | — | $0 | 18,615 | SEC↗ |